Triazole derivative

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C548S265800

Reexamination Certificate

active

07084164

ABSTRACT:
The invention relates to a triazole derivative with an activity inhibiting glycine transporter and for use as a pharmaceutical drug, and a novel triazole derivative. The inventive triazole derivative has an excellent activity inhibiting glycine transporter and is useful as a therapeutic agent of dementia, schizophrenia, cognitive disorders, or cognitive disorders involved in various diseases such as Alzheimer disease, Parkinson's disease, or Huntington disease or the like, or spasm involved in diseases such as nerve degenerative diseases and cerebrovascular disorders, or the like. Particularly, the pharmaceutical drug is useful for the amelioration of learning disability of dementia and the like.

REFERENCES:
patent: 6333326 (2001-12-01), Stobie et al.
patent: 2000-63363 (2000-02-01), None
patent: WO 01/58880 (2001-08-01), None
CA:135:180769 abs of WO 2001058880 Aug. 2001.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Triazole derivative does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Triazole derivative, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Triazole derivative will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3709664

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.